Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Satoh

Showing results (881-890 of 899) with videos related to

Pageof 90
Sort By:
International Archives of Allergy and Immunology|November 18, 1997
Protection against verocytotoxin in mice induced by liposome-coupled verocytotoxinS Naito, A Horino, T Komiya, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 7, 2025
PapMV nanoparticles: A novel pathway to SARS-CoV-2 protection, distinct from ImidazoquinolinesMarilène Bolduc, Philippe Saint-Louis, Damien Carignan, et al.
Nature Genetics|March 4, 2000
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1S Satoh, Y Daigo, Y Furukawa, et al.
Clinical Science (London, England : 1979)|July 1, 1997
Hepatic preservation with histidine-tryptophan-ketoglutarate solution in living-related and cadaveric liver transplantationE Hatano, T Kiuchi, A Tanaka, et al.
Molecular Pharmacology|July 1, 1997
Nonpeptide mimic of bradykinin with long-acting properties at the bradykinin B2 receptorI Aramori, J Zenkoh, N Morikawa, et al.
International Archives of Allergy and Immunology|August 7, 1998
Induction of protection against oral infection with cytotoxin-producing Escherichia coli O157:H7 in mice by shiga-like toxin-liposome conjugateT Fukuda, T Kimiya, M Takahashi, et al.
Developments in Biologicals|September 11, 2002
Status of NAT screening for HCV, HIV and HBV: experience in JapanT Tomono, H Murokawa, K Minegishi, et al.
Human Molecular Genetics|July 7, 2001
Localization of a novel susceptibility gene for familial ovarian cancer to chromosome 3p22-p25M Sekine, H Nagata, S Tsuji, et al.
Immunopharmacology|December 30, 1999
Nonpeptide mimic of bradykinin with long-acting propertiesI Aramori, J Zenkoh, N Morikawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese populationM Sekine, H Nagata, S Tsuji, et al.
Pageof 90

Showing results (881-890 of 899) with videos related to

Sort By:
Pageof 90
International Archives of Allergy and Immunology|November 18, 1997
Protection against verocytotoxin in mice induced by liposome-coupled verocytotoxinS Naito, A Horino, T Komiya, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 7, 2025
PapMV nanoparticles: A novel pathway to SARS-CoV-2 protection, distinct from ImidazoquinolinesMarilène Bolduc, Philippe Saint-Louis, Damien Carignan, et al.
Nature Genetics|March 4, 2000
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1S Satoh, Y Daigo, Y Furukawa, et al.
Clinical Science (London, England : 1979)|July 1, 1997
Hepatic preservation with histidine-tryptophan-ketoglutarate solution in living-related and cadaveric liver transplantationE Hatano, T Kiuchi, A Tanaka, et al.
Molecular Pharmacology|July 1, 1997
Nonpeptide mimic of bradykinin with long-acting properties at the bradykinin B2 receptorI Aramori, J Zenkoh, N Morikawa, et al.
International Archives of Allergy and Immunology|August 7, 1998
Induction of protection against oral infection with cytotoxin-producing Escherichia coli O157:H7 in mice by shiga-like toxin-liposome conjugateT Fukuda, T Kimiya, M Takahashi, et al.
Developments in Biologicals|September 11, 2002
Status of NAT screening for HCV, HIV and HBV: experience in JapanT Tomono, H Murokawa, K Minegishi, et al.
Human Molecular Genetics|July 7, 2001
Localization of a novel susceptibility gene for familial ovarian cancer to chromosome 3p22-p25M Sekine, H Nagata, S Tsuji, et al.
Immunopharmacology|December 30, 1999
Nonpeptide mimic of bradykinin with long-acting propertiesI Aramori, J Zenkoh, N Morikawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese populationM Sekine, H Nagata, S Tsuji, et al.
Pageof 90